Europe Transient Protein Expression Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Transient Protein Expression Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Transient Protein Expression Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Applications of Protein Expression Systems
5.1.2 Surging Popularity of Precision Medicine

5.2 Market Opportunities

5.2.1 Plant-Based Expression Systems for Therapeutic Protein Production

5.3 Future Trends

5.3.1 Integration of Artificial Intelligence (AI) and Automation Technologies

5.4 Impact of Drivers and Restraints

6. Europe Transient Protein Expression Market Regional Analysis

6.1 Europe Transient Protein Expression Market Overview

6.2 Europe Transient Protein Expression Market Revenue 2021-2031 (US$ Million)

6.3 Europe Transient Protein Expression Market Forecast Analysis

7. Europe Transient Protein Expression Market Analysis – by Product Type

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Expression Vectors

7.3.1 Overview
7.3.2 Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Competent Cells

7.4.1 Overview
7.4.2 Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Transient Protein Expression Market Analysis – by Application

8.1 Genomic Research

8.1.1 Overview
8.1.2 Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Gene Therapy

8.2.1 Overview
8.2.2 Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Bio production

8.3.1 Overview
8.3.2 Bio production: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Cancer Research

8.4.1 Overview
8.4.2 Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.5 Drug Development

8.5.1 Overview
8.5.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Transient Protein Expression Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Academic and Research Institutes

9.2.1 Overview
9.2.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Clinical Research Organizations

9.3.1 Overview
9.3.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10. Europe Transient Protein Expression Market – Europe Analysis

10.1 Europe

10.1.1 Europe Transient Protein Expression Market Breakdown, by Key Country, 2024 and 2031 (%)
10.1.1.1 Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 UK: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.1.2 UK: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.1.3 UK: Europe Transient Protein Expression Market Breakdown, by End User

10.1.1.2 Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Germany: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.2.2 Germany: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Transient Protein Expression Market Breakdown, by End User

10.1.1.3 France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 France: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.3.2 France: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.3.3 France: Europe Transient Protein Expression Market Breakdown, by End User

10.1.1.4 Russia: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.4.1 Russia: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.4.2 Russia: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Transient Protein Expression Market Breakdown, by End User

10.1.1.5 Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.5.1 Italy: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.5.2 Italy: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Transient Protein Expression Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Product Type
10.1.1.6.2 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Transient Protein Expression Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Merck KGaA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN NV

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 GenScript Biotech Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Promega Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Takara Bio Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Agilent Technologies Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Mirus Bio LLC

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Bio-Rad Laboratories Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Lonza Group AG

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 MaxCyte Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights